サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1354307

ナノテクノロジーに基づくドラッグデリバリー市場- 技術別、用途別、世界予測、2023年～2032年

Nanotechnology-based Drug Delivery Market - By Technology (Nanocrystals, Nanoparticles, Liposomes, Micelles), Application (Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective), Global Forecast, 2023 - 2032

出版日
ページ情報
英文 110 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ナノテクノロジーに基づくドラッグデリバリー市場- 技術別、用途別、世界予測、2023年～2032年
出版日: 2023年07月13日
発行: Global Market Insights Inc.
ページ情報: 英文 110 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ナノテクノロジーに基づくドラッグデリバリーの世界市場規模は、2023年から2032年にかけて12.5％以上のCAGRで成長する見通しです。

薬物の溶解性とバイオアベイラビリティを向上させるため、ナノ粒子をベースとした経口ドラッグデリバリーシステムを研究する動きが活発化しており、難水溶性薬物のデリバリーに革命をもたらしています。近年、効果的で安全かつ商業的に実行可能なドラッグデリバリープラットフォームの開発に大きな注目が集まっています。バイオテクノロジーとナノ医療分野における汎用性の高いナノキャリアプラットフォームの進歩もまた、市場成長に寄与すると思われます。

ナノテクノロジーに基づくドラッグデリバリー業界全体は、技術、用途、地域によって区分されます。

技術面では、ナノ結晶セグメントの市場規模が2023-2032年に評価できるCAGRで成長する可能性があります。この成長は、特に水溶性の低い化合物において、幅広い薬物の溶解性とバイオアベイラビリティを改善するナノクリスタルの可能性が高まっていることに起因しています。ナノ結晶はまた、溶解に必要な表面積を大幅に増大させ、薬物の溶解性を高めると同時に、凝集や分解を最小限に抑えて安定した薬物製剤を提供します。

用途別では、神経学分野のナノテクノロジーに基づくドラッグデリバリー市場は2032年まで拡大します。ナノ材料とナノ粒子が提供するユニークな特性は、血液脳関門（BBB）だけでなく、脳内の特定領域を横切って薬剤を正確にデリバリーするのに役立ちます。最近、ナノ粒子は、脳卒中中や脳卒中後の脳の損傷を抑えるために、神経保護剤や血栓溶解剤を促進するように設計されています。そのため、世界的に神経疾患や症状の負担が増加していることが、このセグメントの成長に拍車をかけると思われます。

地域的には、APACのナノテクノロジーに基づくドラッグデリバリー産業規模は、2032年まで顕著な成長率を示すと予測されています。これは、中国、日本、韓国、インドにおける投資、政府資金、学術研究、製薬企業との共同研究の増加によるものです。がんの負担が増加していることも、化学療法薬を腫瘍部位に直接送達し、全身的な副作用を抑え、治療効果を高めるナノテクノロジーの必要性を高めています。National Institutes for Healthによると、インドにおける推定がん患者数は2022年に14,61,427人に達します。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 ナノテクノロジーに基づくドラッグデリバリー、業界洞察

  • エコシステム分析
  • 業界への影響要因
    • 成長促進要因
      • 慢性疾患の増加
      • 個別化医薬品への嗜好の高まり
      • ナノ材料の進歩の増加
    • 業界の潜在的リスク＆課題
      • 厳しい規制政策
      • ナノテクノロジーによるドラッグデリバリー技術のコスト高
  • 成長可能性分析
  • COVID-19の影響分析
  • 規制状況
  • 最近の進歩と将来の展望
  • FDA認可のナノテクノロジーに基づく製品と臨床試験
  • ポーターの分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 企業ポジショニングマトリックス
  • 主要市場プレーヤーの競合分析
  • 戦略ダッシュボード

第5章 ナノテクノロジーに基づくドラッグデリバリーの市場規模・予測：技術別

  • 主要動向：技術別
  • ナノクリスタル
  • ナノ粒子
  • リポソーム
  • ミセル
  • その他の技術

第6章 ナノテクノロジーに基づくドラッグデリバリーの市場規模・予測：用途別

  • 主要動向：用途別
  • 神経
  • 腫瘍学
  • 循環器/生理学
  • 抗炎症/免疫学
  • 抗感染症
  • その他の用途

第7章 ナノテクノロジーに基づくドラッグデリバリーの市場規模・予測：地域別

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他中東とアフリカ

第8章 企業プロファイル

  • AbbVie Inc.
  • BlueWillow Biologics
  • Camurus AB
  • Celgene, Inc.
  • Cristal Therapeutics
  • Johnson and Johnson
  • Merck and Co., Inc
  • Nanobiotix
  • NanoCarrier Co. Ltd.
  • NanOlogy LLC
  • Novartis International AG
  • Starpharma Holdings Limited
図表

Data Tables

  • TABLE 1 Market revenue, by technology (2022)
  • TABLE 2 Market share, by application (2022)
  • TABLE 3 Market share, by region (2022)
  • TABLE 4 Global nanotechnology-based drug delivery market size, by region, 2018-2022 (USD Million)
  • TABLE 5 Global nanotechnology-based drug delivery market size, by region, 2023-2032 (USD Million)
  • TABLE 6 Global nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 7 Global nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 8 Global nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 9 Global nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 10 Industry impact forces
  • TABLE 11 Nanocrystals market size, 2018-2022 (USD Million)
  • TABLE 12 Nanocrystals market size, 2023-2032 (USD Million)
  • TABLE 13 Nanoparticles market size, 2018-2022 (USD Million)
  • TABLE 14 Nanoparticles market size, 2023-2032 (USD Million)
  • TABLE 15 Liposomes market size, 2018-2022 (USD Million)
  • TABLE 16 Liposomes market size, 2023-2032 (USD Million)
  • TABLE 17 Micelles market size, 2018-2022 (USD Million)
  • TABLE 18 Micelles market size, 2023-2032 (USD Million)
  • TABLE 19 Other technologies market size, 2018-2022 (USD Million)
  • TABLE 20 Other technologies market size, 2023-2032 (USD Million)
  • TABLE 21 Neurology market size, 2018-2022 (USD Million)
  • TABLE 22 Neurology market size, 2023-2032 (USD Million)
  • TABLE 23 Oncology market size, 2018-2022 (USD Million)
  • TABLE 24 Oncology market size, 2023-2032 (USD Million)
  • TABLE 25 Cardiovascular/physiology market size, 2018-2022 (USD Million)
  • TABLE 26 Cardiovascular/physiology market size, 2023-2032 (USD Million)
  • TABLE 27 Anti-inflammatory/immunology market size, 2018-2022 (USD Million)
  • TABLE 28 Anti-inflammatory/immunology market size, 2023-2032 (USD Million)
  • TABLE 29 Anti-infective market size, 2018-2022 (USD Million)
  • TABLE 30 Anti-infective market size, 2023-2032 (USD Million)
  • TABLE 31 Other applications market size, 2018-2022 (USD Million)
  • TABLE 32 Other applications market size, 2023-2032 (USD Million)
  • TABLE 33 North America nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
  • TABLE 34 North America nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
  • TABLE 35 North America nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 36 North America nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 37 North America nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 38 North America nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 39 U.S. nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 40 U.S. nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 41 U.S. nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 42 U.S. nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 43 Canada nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 44 Canada nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 45 Canada nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 46 Canada nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 47 Europe nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
  • TABLE 48 Europe nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
  • TABLE 49 Europe nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 50 Europe nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 51 Europe nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 52 Europe nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 53 Germany nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 54 Germany nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 55 Germany nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 56 Germany nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 57 UK nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 58 UK nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 59 UK nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 60 UK nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 61 France nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 62 France nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 63 France nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 64 France nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 65 Spain nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 66 Spain nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 67 Spain nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 68 Spain nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 69 Italy nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 70 Italy nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 71 Italy nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 72 Italy nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 73 Rest of Europe nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 74 Rest of Europe nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 75 Rest of Europe nanotechnology-based drug delivery market size, application, 2018-2022 (USD Million)
  • TABLE 76 Rest of Europe nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 77 Asia Pacific nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
  • TABLE 78 Asia Pacific nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
  • TABLE 79 Asia Pacific nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 80 Asia Pacific nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 81 Asia Pacific nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 82 Asia Pacific nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 83 Japan nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 84 Japan nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 85 Japan nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 86 Japan nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 87 China nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 88 China nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 89 China nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 90 China nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 91 India nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 92 India nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 93 India nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 94 India nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 95 Australia nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 96 Australia nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 97 Australia nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 98 Australia nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 99 Rest of Asia pacific nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 100 Rest of Asia pacific nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 101 Rest of Asia Pacific nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 102 Rest of Asia Pacific nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 103 Latin America nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
  • TABLE 104 Latin America nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
  • TABLE 105 Latin America nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 106 Latin America nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 107 Latin America nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 108 Latin America nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 109 Brazil nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 110 Brazil nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 111 Brazil nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 112 Brazil nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 113 Mexico nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 114 Mexico nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 115 Mexico nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 116 Mexico nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 117 Argentina nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 118 Argentina nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 119 Argentina nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 120 Argentina nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 121 Rest of Latin America nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 122 Rest of Latin America nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 123 Rest of Latin America nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 124 Rest of Latin America nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 125 Middle East & Africa nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
  • TABLE 126 Middle East & Africa nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
  • TABLE 127 Middle East & Africa nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 128 Middle East & Africa nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 129 Middle East & Africa nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 130 Middle East & Africa nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 131 South Africa nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 132 South Africa nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 133 South Africa nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 134 South Africa nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 135 Saudi Arabia nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 136 Saudi Arabia nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 137 Saudi Arabia nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
  • TABLE 138 Saudi Arabia nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
  • TABLE 139 Rest of Middle East & Africa nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
  • TABLE 140 Rest of Middle East & Africa nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
  • TABLE 141 Rest of Middle East & Africa nanotechnology-based drug delivery market size, application, 2018-2022 (USD Million)
  • TABLE 142 Rest of Middle East & Africa nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Nanotechnology-based drug delivery industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by technology
  • FIG 8 Growth potential analysis, by application
  • FIG 9 Porter's analysis
  • FIG 10 PESTEL analysis
  • FIG 11 Company matrix analysis, 2022
  • FIG 12 Competitive analysis of major market players, 2022
  • FIG 13 Competitive positioning matrix
  • FIG 14 Strategic dashboard, 2022
目次
Product Code: 6208

Global nanotechnology-based drug delivery market size is poised to record over 12.5% CAGR from 2023-2032. The rising number of research activities for exploring nanoparticle-based oral drug delivery systems to offer improved drug solubility and bioavailability is revolutionizing the delivery of poorly water-soluble drugs. In recent years, there has been significant focus on the development of effective, safe, and commercially viable drug delivery platforms. The increasing advances in versatile nanocarrier platforms within the biotechnology and nanomedicine space will also contribute to the market growth.

The overall nanotechnology-based drug delivery industry is segmented based on technology, application, and region.

In terms of technology, the market size from the nanocrystals segment may record appreciable CAGR from 2023-2032. The growth can be attributed to the rising potential of nanocrystals in improving the solubility and bioavailability of wide range of drugs, especially in poorly water-soluble compounds. Nanocrystals also significantly augment the surface area needed for dissolution to render enhanced drug solubility whilst providing stable drug formulations via minimal aggregation and degradation.

With respect to application, the nanotechnology-based drug delivery market from the neurology segment will expand up to 2032. The unique properties offered by nanomaterials and nanoparticles help in the precise delivery of drugs across blood-brain barrier (BBB) as well as specific regions within the brain. Lately, nanoparticles are also engineered to facilitate neuroprotective agents and clot-dissolving drugs to limit brain damage during and after strokes. To that end, the rising burden of neurological disorders and conditions worldwide will add to the segment growth.

Regionally, APAC nanotechnology-based drug delivery industry size is projected to observe notable growth rate through 2032. This is due to the rising investments, government funding, academic research, as well as collaborations with pharmaceutical companies in China, Japan, South Korea, and India. The growing burden of cancer is also driving the need for nanotechnology in delivering chemotherapy drugs directly to tumor sites, limiting systemic side effects and enhancing the treatment outcomes. As per the National Institutes for Health, the estimated number of cancer cases in India reached 14,61,427 in 2022.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Global nanotechnology-based drug delivery market 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Technology trends
    • 2.1.4 Application trends

Chapter 3 Nanotechnology-based Drug Delivery Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of chronic conditions
      • 3.2.1.2 Increasing preference for personalized medicines
      • 3.2.1.3 Increasing advancements in nanomaterials
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulatory policies
      • 3.2.2.2 High cost of nanotechnology drug delivery technique
  • 3.3 Growth potential analysis
    • 3.3.1 By technology
    • 3.3.2 By application
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Recent advancement and future prospects
  • 3.7 FDA-approved nanotechnology-based products and clinical trials
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Company positioning matrix
  • 4.4 Competitive analysis of major market players
  • 4.5 Strategy dashboard, 2022

Chapter 5 Nanotechnology-based Drug Delivery Market Size and Forecast, By Technology (USD Million)

  • 5.1 Key trends, by technology
  • 5.2 Nanocrystals
  • 5.3 Nanoparticles
  • 5.4 Liposomes
  • 5.5 Micelles
  • 5.6 Other technologies

Chapter 6 Nanotechnology-based Drug Delivery Market Size and Forecast, By Application (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Neurology
  • 6.3 Oncology
  • 6.4 Cardiovascular/Physiology
  • 6.5 Anti-inflammatory/Immunology
  • 6.6 Anti-infective
  • 6.7 Other applications

Chapter 7 Nanotechnology-based Drug Delivery Market Size and Forecast, By Region (USD Million)

  • 7.1 Key trends, by region
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East & Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 Rest of Middle East & Africa

Chapter 8 Company Profiles

  • 8.1 AbbVie Inc.
  • 8.2 BlueWillow Biologics
  • 8.3 Camurus AB
  • 8.4 Celgene, Inc.
  • 8.5 Cristal Therapeutics
  • 8.6 Johnson and Johnson
  • 8.7 Merck and Co., Inc
  • 8.8 Nanobiotix
  • 8.9 NanoCarrier Co. Ltd.
  • 8.10 NanOlogy LLC
  • 8.11 Novartis International AG
  • 8.12 Starpharma Holdings Limited